Enveric Biosciences Inc vs Expensify Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Expensify Inc trades at $2.27 (market cap $209.73M). The key difference: Expensify Inc is far larger — about 33.8× Enveric Biosciences Inc's market cap, and Expensify Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | EXFY | |
|---|---|---|
Market Cap | $6.20M | $209.73M |
Sector | Health | Technology |
52-Week High | $17.40 | $2.69 |
52-Week Low | $1.27 | $0.75 |
Enterprise Value | $1.30M | $149.35M |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →